SCHEMBL7011748

SCHEMBL7011748

CCOC(=O)c1c(-c2ccc(O)cc2)[nH]c2cc(N3CCN(O)CC3)c(F)cc2c1=O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 6/20 0.46
KDM4E B2RXH2 4/20 0.45
ALDH1A1 P00352 4/20 0.45
HPGD P15428 4/20 0.45
HSD17B10 Q99714 4/20 0.45
GAA P10253 3/20 0.45
MAPT P10636 2/20 0.45
MEN1 O00255 1/20 0.45
LMNA P02545 1/20 0.45
MAPK10 P53779 1/20 0.45
KMT2A Q03164 1/20 0.45
POLB P06746 1/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
NPC1 O15118 1/20 0.43
KIF11 P52732 2/20 0.41
PTGES O14684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7020424 0.91 ALOX5 (0.46) ALOX5KDM4EALDH1A1HPGDHSD17B10
SCHEMBL7149603 0.86 ALOX5 (0.43) ALOX5KDM4EALDH1A1HPGDHSD17B10
SCHEMBL7013967 0.85 PRKD3 (0.42) ALOX5KDM4EALDH1A1HPGDHSD17B10
SCHEMBL7010787 0.84 ALOX5 (0.56) ALOX5KDM4EALDH1A1HPGDHSD17B10
SCHEMBL7014803 0.82 KIF11 (0.52) ALOX5KDM4EALDH1A1HPGDHSD17B10
SCHEMBL7013585 0.79 KDM4E (0.42) ALOX5KDM4EALDH1A1HPGDHSD17B10
SCHEMBL7015629 0.79 KDM4E (0.41) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL7018451 0.77 ALOX5 (0.49) ALOX5KDM4EALDH1A1HPGDHSD17B10
SCHEMBL11208613 0.75 GAA (0.47) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL7016620 0.73 KIF11 (0.42) KDM4EALDH1A1HPGDHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313708-A1 QUINOLINE ANTIBACTERIAL COMPOUNDS AND METHODS OF USE THEREOF CHIRON CORPORATION (US) 2003-05-28 EP disclosed
WO-2002018345-A1 QUINOLINE ANTIBACTERIAL COMPOUNDS AND METHODS OF USE THEREOF CHIRON CORPORATION (US) 2002-03-07 WO disclosed